APA (7th ed.) Citation

Estadt, A. T., Kline, D., Miller, W. C., Feinberg, J., Hurt, C. B., Mixson, L. S., . . . Lancaster, K. E. (2024). Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduction Journal, 21(1), . https://doi.org/10.1186/s12954-024-01131-6

Chicago Style (17th ed.) Citation

Estadt, Angela T., et al. "Differences in Hepatitis C Virus (HCV) Testing and Treatment by Opioid, Stimulant, and Polysubstance Use Among People Who Use Drugs in Rural U.S. Communities." Harm Reduction Journal 21, no. 1 (2024). https://doi.org/10.1186/s12954-024-01131-6.

MLA (9th ed.) Citation

Estadt, Angela T., et al. "Differences in Hepatitis C Virus (HCV) Testing and Treatment by Opioid, Stimulant, and Polysubstance Use Among People Who Use Drugs in Rural U.S. Communities." Harm Reduction Journal, vol. 21, no. 1, 2024, https://doi.org/10.1186/s12954-024-01131-6.